XML 45 R35.htm IDEA: XBRL DOCUMENT v3.21.2
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
May 26, 2021
Apr. 29, 2021
Feb. 25, 2021
Feb. 25, 2020
Jan. 02, 2017
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]                      
Proceeds from Issuance Initial Public Offering   $ 11,700,000                  
Stock options outstanding           5,493,861     5,493,861   5,597,861
Stock options outstanding weighted average exercise price           $ 1.84     $ 1.84   $ 1.47
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value           $ 5,701,038     $ 5,701,038    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                 546,000    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                 $ 4.96    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term                 6 years 5 months 23 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares                 433,979    
Stock issued during the period exercised                 370,000    
Commom stock issued           16,263,634     16,263,634   10,360,480
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number           6,132,630     6,132,630   4,007,058
Common Stock [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Stock issued during the period exercised           360,000 10,000        
Commom stock issued           360,000     360,000    
Proceeds from Stock Options Exercised           $ 532,500          
Warrants outstanding           836,558 240,123   836,558    
Proceeds from warrants exercised           $ 300,000 $ 27,125        
Warrant [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Stock issued during the period exercised           1,008,137          
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number           6,132,630     6,132,630    
Class of warrant or right, outstanding, weighted average exercise price           $ 3.38     $ 3.38    
Class of warrant or right, outstanding, intrinsic value           $ 4,629,869     $ 4,629,869    
Warrants outstanding             373,042        
Options To Related Party [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Stock options outstanding           10,000     10,000    
Stock options outstanding weighted average exercise price           $ 1.00     $ 1.00    
Stock issued during the period exercised                 10,000    
Options To Related Party [Member] | Common Stock [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Warrants outstanding           231,277     231,277    
Employees [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Payment Arrangement, Expense               $ 528,197      
Unamortized stock option expense           $ 343,794     $ 343,794    
Non-Employees [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Payment Arrangement, Expense               194,769 404,541    
Unamortized stock option expense           $ 2,197,663     $ 2,197,663    
2016 Plan [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Number of additional shares grants for issuance         564,378            
Number of shares available for grant         1,693,134 4,868,623     4,868,623   4,868,623
Series B Prefered Stock [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Preferred Stock, Convertible, Shares Issuable           436,749     436,749    
Common Stock [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Preferred Stock, Convertible, Shares Issuable           436,749     436,749    
Share-based Payment Arrangement, Option [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                 546,000    
Share-based Payment Arrangement, Expense           $ 722,966   304,148 $ 664,400 $ 1,387,497  
Share-based Payment Arrangement, Option [Member] | Settlement of Accrued Compensation [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 180,000                    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 3.65     $ 5.60              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value $ 474,231     $ 2,009,063              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 10 years                    
Share-based Payment Arrangement, Option [Member] | Options Vested Over 48 Months [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares     16,000 350,000              
Share-based Payment Arrangement, Option [Member] | 5 Individuals [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross     366,000                
Share-based Payment Arrangement, Option [Member] | Related Parties [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       350,000              
Share-based Payment Arrangement, Option [Member] | General and Administrative Expense [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Payment Arrangement, Expense           721,490   269,408 1,065,988 595,202  
Share-based Payment Arrangement, Option [Member] | Research and Development Expense [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Payment Arrangement, Expense           1,476   $ 34,740 2,953 $ 69,381  
Share-based Payment Arrangement, Option [Member] | Minimum [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                   $ 3.65  
Share-based Payment Arrangement, Option [Member] | Minimum [Member] | Settlement of Accrued Compensation [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term       5 years              
Share-based Payment Arrangement, Option [Member] | Maximum [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                   $ 5.60  
Share-based Payment Arrangement, Option [Member] | Maximum [Member] | Settlement of Accrued Compensation [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term       10 years              
Equity Option [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share-based Payment Arrangement, Expense                 1,068,941 $ 751,552  
Unamortized stock option expense           $ 2,541,457     $ 2,541,457    
IPO [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Stock Issued During Period, Shares, New Issues   3,180,000                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   3,180,000                  
IPO [Member] | 45-day Option [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   477,000